Topotecan - NDC Database


17 records found:

Sorted by NDC Code

Page of 1
0069-0075 Aug 29, 2012
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Pfizer Laboratories Div Pfizer Inc.
0409-0302 Sep 24, 2013
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
0703-4714 May 21, 2013
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc.
16729-151 Jul 23, 2013
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
25021-206 Nov 28, 2010
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
25021-236 Dec 15, 2014
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Sagent Pharmaceuticals
25021-824 Jun 27, 2011
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
45963-615 Jan 05, 2015
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
50742-404 Dec 07, 2016
Topotecan 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Ingenus Pharmaceuticals, LLC
55390-370 Apr 18, 2011
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
62756-023 Sep 02, 2015
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Sun Pharmaceutical Industries Limited
63323-762 Sep 16, 2015
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
66435-410 Dec 02, 2010
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, for Solution by Three Rivers Pharmaceuticals, LLC.
66758-051 Feb 25, 2011
Topotecan 1 mg/ml Intravenous Injection by Sandoz Inc
67457-474 Aug 29, 2012
Topotecan Hydrochloride 4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
67457-662 Apr 09, 2018
Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Mylan Institutional LLC
69097-262 Dec 01, 2010
Topotecan Hydrochloride 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Cipla USA Inc.

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 August 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA